Selected research
Industry Research
Aminocaproic Acid Injection Industry Research Report 2026
Market perspective
The global Aminocaproic Acid Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aminocaproic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aminocaproic Acid Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aminocaproic Acid Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aminocaproic Acid Injection include Civica, Baiao Pharmaceutical, Changzhou Lanling Pharmaceutical, Chengdu Brilliant Pharmaceutical, Daiichi Sankyo, Guangdong Wonterfull ITD Pharmaceutical, Hunan Er-Kang Pharmaceutical, Pfizer and Jiangsu Yuexing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aminocaproic Acid Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aminocaproic Acid Injection Market by Company
Civica
Baiao Pharmaceutical
Changzhou Lanling Pharmaceutical
Chengdu Brilliant Pharmaceutical
Daiichi Sankyo
Guangdong Wonterfull ITD Pharmaceutical
Hunan Er-Kang Pharmaceutical
Pfizer
Jiangsu Yuexing Pharmaceutical
Southwest Pharmaceutical
Yangzhou Zhongbao Pharmaceutical
Aminocaproic Acid Injection Segment by Type
20ml
8ml
Other
Aminocaproic Acid Injection Segment by Application
Hospital
Clinic
Other
Aminocaproic Acid Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminocaproic Acid Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aminocaproic Acid Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminocaproic Acid Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aminocaproic Acid Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aminocaproic Acid Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aminocaproic Acid Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20ml
- 8ml
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Civica
- Baiao Pharmaceutical
- Changzhou Lanling Pharmaceutical
- Chengdu Brilliant Pharmaceutical
- Daiichi Sankyo
- Guangdong Wonterfull ITD Pharmaceutical
- Hunan Er-Kang Pharmaceutical
- Pfizer
- Jiangsu Yuexing Pharmaceutical
- Southwest Pharmaceutical
- Yangzhou Zhongbao Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aminocaproic Acid Injection Market Size (2021-2032)
- 2.2.2 Global Aminocaproic Acid Injection Sales (2021-2032)
- 2.2.3 Global Aminocaproic Acid Injection Market Average Price (2021-2032)
- 2.3 Aminocaproic Acid Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20ml
- 2.3.3 8ml
- 2.3.4 Other
- 2.4 Aminocaproic Acid Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aminocaproic Acid Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aminocaproic Acid Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Aminocaproic Acid Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Aminocaproic Acid Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Aminocaproic Acid Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aminocaproic Acid Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aminocaproic Acid Injection, Product Type & Application
- 3.8 Global Manufacturers of Aminocaproic Acid Injection, Established Date
- 3.9 Global Aminocaproic Acid Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Civica
- 4.1.1 Civica Company Information
- 4.1.2 Civica Business Overview
- 4.1.3 Civica Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Civica Aminocaproic Acid Injection Product Portfolio
- 4.1.5 Civica Recent Developments
- 4.2 Baiao Pharmaceutical
- 4.2.1 Baiao Pharmaceutical Company Information
- 4.2.2 Baiao Pharmaceutical Business Overview
- 4.2.3 Baiao Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baiao Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.2.5 Baiao Pharmaceutical Recent Developments
- 4.3 Changzhou Lanling Pharmaceutical
- 4.3.1 Changzhou Lanling Pharmaceutical Company Information
- 4.3.2 Changzhou Lanling Pharmaceutical Business Overview
- 4.3.3 Changzhou Lanling Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Changzhou Lanling Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.3.5 Changzhou Lanling Pharmaceutical Recent Developments
- 4.4 Chengdu Brilliant Pharmaceutical
- 4.4.1 Chengdu Brilliant Pharmaceutical Company Information
- 4.4.2 Chengdu Brilliant Pharmaceutical Business Overview
- 4.4.3 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.4.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 4.5 Daiichi Sankyo
- 4.5.1 Daiichi Sankyo Company Information
- 4.5.2 Daiichi Sankyo Business Overview
- 4.5.3 Daiichi Sankyo Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Daiichi Sankyo Aminocaproic Acid Injection Product Portfolio
- 4.5.5 Daiichi Sankyo Recent Developments
- 4.6 Guangdong Wonterfull ITD Pharmaceutical
- 4.6.1 Guangdong Wonterfull ITD Pharmaceutical Company Information
- 4.6.2 Guangdong Wonterfull ITD Pharmaceutical Business Overview
- 4.6.3 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.6.5 Guangdong Wonterfull ITD Pharmaceutical Recent Developments
- 4.7 Hunan Er-Kang Pharmaceutical
- 4.7.1 Hunan Er-Kang Pharmaceutical Company Information
- 4.7.2 Hunan Er-Kang Pharmaceutical Business Overview
- 4.7.3 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.7.5 Hunan Er-Kang Pharmaceutical Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Aminocaproic Acid Injection Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Jiangsu Yuexing Pharmaceutical
- 4.9.1 Jiangsu Yuexing Pharmaceutical Company Information
- 4.9.2 Jiangsu Yuexing Pharmaceutical Business Overview
- 4.9.3 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.9.5 Jiangsu Yuexing Pharmaceutical Recent Developments
- 4.10 Southwest Pharmaceutical
- 4.10.1 Southwest Pharmaceutical Company Information
- 4.10.2 Southwest Pharmaceutical Business Overview
- 4.10.3 Southwest Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Southwest Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.10.5 Southwest Pharmaceutical Recent Developments
- 4.11 Yangzhou Zhongbao Pharmaceutical
- 4.11.1 Yangzhou Zhongbao Pharmaceutical Company Information
- 4.11.2 Yangzhou Zhongbao Pharmaceutical Business Overview
- 4.11.3 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 4.11.5 Yangzhou Zhongbao Pharmaceutical Recent Developments
5 Global Aminocaproic Acid Injection Market Scenario by Region
- 5.1 Global Aminocaproic Acid Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aminocaproic Acid Injection Sales by Region: 2021-2032
- 5.2.1 Global Aminocaproic Acid Injection Sales by Region: 2021-2026
- 5.2.2 Global Aminocaproic Acid Injection Sales by Region: 2027-2032
- 5.3 Global Aminocaproic Acid Injection Revenue by Region: 2021-2032
- 5.3.1 Global Aminocaproic Acid Injection Revenue by Region: 2021-2026
- 5.3.2 Global Aminocaproic Acid Injection Revenue by Region: 2027-2032
- 5.4 North America Aminocaproic Acid Injection Market Facts & Figures by Country
- 5.4.1 North America Aminocaproic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aminocaproic Acid Injection Sales by Country (2021-2032)
- 5.4.3 North America Aminocaproic Acid Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Aminocaproic Acid Injection Market Facts & Figures by Country
- 5.5.1 Europe Aminocaproic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aminocaproic Acid Injection Sales by Country (2021-2032)
- 5.5.3 Europe Aminocaproic Acid Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Aminocaproic Acid Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aminocaproic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aminocaproic Acid Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aminocaproic Acid Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aminocaproic Acid Injection Market Facts & Figures by Country
- 5.7.1 South America Aminocaproic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aminocaproic Acid Injection Sales by Country (2021-2032)
- 5.7.3 South America Aminocaproic Acid Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Aminocaproic Acid Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aminocaproic Acid Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aminocaproic Acid Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aminocaproic Acid Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Aminocaproic Acid Injection Sales by Type (2021-2032)
- 6.1.1 Global Aminocaproic Acid Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Aminocaproic Acid Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Aminocaproic Acid Injection Revenue by Type (2021-2032)
- 6.2.1 Global Aminocaproic Acid Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aminocaproic Acid Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Aminocaproic Acid Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aminocaproic Acid Injection Sales by Application (2021-2032)
- 7.1.1 Global Aminocaproic Acid Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Aminocaproic Acid Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Aminocaproic Acid Injection Revenue by Application (2021-2032)
- 7.2.1 Global Aminocaproic Acid Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aminocaproic Acid Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Aminocaproic Acid Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aminocaproic Acid Injection Value Chain Analysis
- 8.1.1 Aminocaproic Acid Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aminocaproic Acid Injection Production Mode & Process
- 8.2 Aminocaproic Acid Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aminocaproic Acid Injection Distributors
- 8.2.3 Aminocaproic Acid Injection Customers
9 Global Aminocaproic Acid Injection Analyzing Market Dynamics
- 9.1 Aminocaproic Acid Injection Industry Trends
- 9.2 Aminocaproic Acid Injection Industry Drivers
- 9.3 Aminocaproic Acid Injection Industry Opportunities and Challenges
- 9.4 Aminocaproic Acid Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst